Three months later, after considering the FDA Advisory Committee
recommendation, the two-year study data, and the TOUCH Prescribing
Program developed by the product management team, the FDA once again
approved Tysabri for the treatment of relapsing-remitting MS. The
product management team had overcome a historic challenge to fulfill
both Biogen Idec's commitment and the imperative set by thousands
of patients with MS across the United States: Tysabri was back on the
market.
TYSABRI[R] THE TYSABRI BRAND TEAM
U.S. Neurology, Marketing Director Irene Hunt
Associate Director, Marketing Dallan Murray
Associate Director, Marketing Anissa Kalinowski
Associate Director, Marketing Anna Diaz-Triola
U.S. Neurology Sarah Garner
U.S. Neurology, Associate Director Market Research Carl Olson
Marketing Emilie Beskar
Gold Award Winner: Consumer Marketing
The Nexium Marketing Team
AstraZeneca
Recently, in the midst of an increasingly competitive market (with
both prescription and OTC medications), it has become more important
than ever to keep Nexium (esomeprazole magnesium) positioned as a leader
on-line: to not only keep it top of mind with the consumer, but also
position it as the leading prescription acid reflux treatment. The
Nexium consumer on-line marketing team has been up to the challenge, and
for good reason.
Acid reflux is a serious condition, which untreated (or treated
incorrectly) over time can lead to severe damage of the esophagus.
Recent statistics from the U.S. Department of Health and Human Services
indicate that approximately 20 million people in the United States alone
suffer from acid reflux disease. Many may not understand the severity of
their condition or realize that they may need a prescription medication
to treat it. These individuals are either taking an array of OTC
heartburn medicines or simply are ignoring their condition. Therefore,
educating this audience on acid reflux disease, getting them to realize
its severity, and ultimately getting them to speak with their doctor are
all key marketing challenges that the team needed to address.
The on-line media plan needed to reach individuals 35 years of age
or older, suffering from acid reflux at least two times weekly. These
individuals may or may not have already been diagnosed with acid reflux
disease, and they may or may not be taking a prescription or OTC
medication to treat their condition.
Specific campaign objectives included cost-efficient coupon
downloads, qualified site traffic, overall brand awareness among
diagnosed and nondiagnosed individuals, innovative targeting and
segmentation, influencing consumers to talk with their doctor about
Nexium, and switching competitor users to Nexium.
To achieve these objectives, the team needed to develop tactics
that expanded across a full spectrum of areas. The end result was an
on-line campaign that embraced elements of strategic targeting,
innovative research, paid search, CPA (cost per acquisition) and CPM
(cost per thousand) programs, as well as direct response, E-mail,
sponsorships, and rich media.
Knowing that the target audience uses the Web to research medical
conditions, it was extremely important for us to align Nexium with
trusted third-party content on-line, as well as ensure that when people
searched relevant terms on major search engines, they saw Nexium's
message. In addition, the creative team needed to turn on-line ads into
engaging resource centers, to provide the necessary level of information
to the target audience. Working closely with our off-line teams has
helped us develop a seamless, fully integrated campaign with multiple
on-line elements.
Sponsorships on English and Hispanic health sites aligned Nexium
with trusted third-party content and gave users access to expert content
on demand. Sponsorships included exclusive acid reflux centers across
leading online health sites. These acid reflux centers were in-depth
resource environments for users. One center included more than 60 expert
articles ranging from digestive health myths to heartburn treatment
options.
For the acid reflux centers on the Hispanic sites, all creative
running in these areas was translated and adopted for the Hispanic
audience, and drove to Spanish versions of the consumer website. In
addition to establishing market leadership and brand awareness with this
audience, Nexium conducted brand awareness research to evaluate the
affect of Nexium messaging on the Hispanic audience, and modified the ad
units to improve their effectiveness and performance.
Rich media, such as PointRoll expand banners, provided users with
deeper levels of education (including tips for talking with their
doctor), as well as the opportunity to register for a free trial coupon
within the banner space. Also, ShoshTV video units extended the latest
television spot on-line; a talking avatar of a virtual doctor (using
Oddcast technology) allowed users to take a quiz on heartburn in a
banner. Depending on the answers, users would get a result screen
tailored to the current state of their heartburn condition.
Getting the Nexium message in front of the right audience was
critical to the on-line campaign's success. To do so, media buys
ranging from paid search, to CPM, to CPA were utilized. Paid search
assured Nexium's presence (in top positions) against all "acid
reflux" related key words, for all users searching for acid reflux
information. The search creative was continuously optimized throughout
the year to drive traffic, and capitalized on current events related to
Nexium. Numerous CPM buys gave Nexium the reach needed to establish a
strong presence across the Web, and CPA buys allowed for efficient
registration downloads for a Nexium seven-day free trial coupon.
Targeting played a critical role in driving more efficiency out of
the CPM media campaigns. From behavioral to demo targeting, increased
targeting helped us better understand the Nexium customer's on-line
behavior. A test program with one site allowed us to remessage to
individuals up to two days after they searched for acid reflux and
heartburn-related content on-line, thus giving us the opportunity to
reach consumers actively interested in the condition.
In addition, a redesigned consumer website gave users an enhanced
brand experience. To provide the best possible experience for sufferers
of heartburn and acid reflux disease, the Nexium website was completely
redesigned for 2006. With personalization and customization at its core,
every aspect of the new site had the user in mind. A tool named the
Personal Pal allows users to tailor their site experience based on who
they are. By answering a simple qualification question, users are given
a path to information most relevant to them. For example, if someone is
curious about their condition, they will be given a different experience
than someone ready to address their pain.
Other core site features include three-dimensional flash-based
animations that detail the digestive system, explain the acid reflux
condition, and describe how Nexium works; a full function meal-planner;
and the ability to sign up for pill and refill reminders by E-mail.
The new Nexium website continues to be one of the most visited and
relied-on sources of information on heartburn/ acid reflux, and ranks
consistently in the top 3 most visited health sites, according to
Hitwise. In addition to English, content is also available in Spanish.
Nexium[R] (esomeprazole magnesium)
THE NEXIUM MARKETING TEAM
Senior ePromotions Manager, AstraZeneca Jean Pundiak
Internet Support Manager, AstraZeneca Heath Weber
ePromotions Manager, Patient Marketing Jason Stein
Account Supervisor, Avenue A/Razorfish Frank Faita
Account Director, Avenue A/Razorfish Christopher Harris
Account Executive, Avenue A/Razorfish Jamie Klimberg
Media Planner, Avenue A/Razorfish Jim Crews
Associate Media Director, Avenue A/ Razorfish Jason Hoffmann
Account Director, Tribal DDB Christian Dietrich
Account Supervisor, Tribal DDB Allison Koplik
Silver Award Winner: Consumer Marketing
The Stop Hep B Campaign
Gilead Sciences, Inc.
Gilead Sciences is and has been the market leader in combating
hepatitis B. Although a new competitor entered the market shortly before
the launch of the Stop Hep B campaign, Gilead's marketshare has not
eroded, owing in part to this campaign. The Stop Hep B team at Gilead
developed an innovative, unbranded campaign with the objective of
raising awareness of hepatitis B and the importance of getting screened
for the disease. The prevalence of the disease among Asian Americans was
also determined to be a focal point, as one in 10 Asian Americans is at
risk for the disease.
The team created an in-language viral program that involved both
patients and caregivers. The Hep B Warriors, or vocal advocates, helped
spread the message about the importance of screening. Warriors are
provided with training and tools at www.stophepb.com. At the site,
Warriors have the opportunity to learn about the disease, participate in
a training module and quiz, and learn new ways to spread the word about
getting tested. They also learn about blogging, how it works, how to
create one, and how to post to other blogs. Once training is completed
and Warriors begin spreading the word, they report back on what they
have done, whether it is sharing information at a community event or
blogging on-line. The more activities a Warrior participates in, the
closer he or she gets to attaining a virtual black belt.
COPYRIGHT 2006 Medicom International,
Inc. Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2006, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.